CytomX Therapeutics CTMX Amortization of capitalized software and acquired intangible assets
Amortization of capitalized software and acquired intangible assets at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's amortization of capitalized software and acquired intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's amortization of capitalized software and acquired intangible assets?
- CytomX Therapeutics (CTMX) reported amortization of capitalized software and acquired intangible assets of $37K in Q1 2026.
- How has CytomX Therapeutics's amortization of capitalized software and acquired intangible assets changed year-over-year?
- CytomX Therapeutics's amortization of capitalized software and acquired intangible assets increased by 2.8% year-over-year, from $36K to $37K.
- What is the long-term trend for CytomX Therapeutics's amortization of capitalized software and acquired intangible assets?
- Over 4 years (2021 to 2025), CytomX Therapeutics's amortization of capitalized software and acquired intangible assets has grown at a 0.0% compound annual growth rate (CAGR), from $146K to $146K.